GENEVA, Aug. 12 -- TRIS PHARMA, INC. (2031 US Highway 130Monmouth junction, New Jersey 08852) filed a patent application (PCT/US2024/014162) for "LIQUID CLONIDINE EXTENDED RELEASE COMPOSITION" on Feb 02, 2024. With publication no. WO/2025/165367, the details related to the patent application was published on Aug 07, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PATEL, Grishma (171 Stults LaneEast Brunswick, New Jersey 08816)
Abstract:
An oral clonidine dosage unit providing a twenty-four hour extended release profile following a single dose administration is provided. The dosage unit co...